Neudle.com: "Parkinson disease etiology of"

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acoustic nerve

acoustic neurinoma

advances in neurology

adverse drug reaction

alcohol intolerance

alkylating agents

alpha-synuclein

altered states of consciousness

alternating hemiplegia

alternating hemiplegia of childhood

Alzheimer's disease

amaurosis fugax

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

anemia

animal exposure

anti basal ganglia antibodies

anticholinergic drugs

anticipation

anticoagulant, complications of

anticoagulant, treatment in CVD

antimetabolite

antistreptolysin titer

autonomic dysfunction

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

blood dyscrasias, neurologic findings with

botulinum toxin

bradykinesia

brain transplantation

CAT scan, stereotactic localization

central nervous system, infection of

cerebellar edema

cerebellar lesion

cerebellitis

cerebellum, disease of

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, intraventricular

cerebrospinal fluid, pressure low

cerebrovascular accident

cerebrovascular accident, young adult

cerebrovascular disease, risk factors in

Charcot-Marie-Tooth

chemotherapy, CNS treatment and complications with

children

chorea

chromosomal abnormality

chromosome 14

cigarette smoking

climate change

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

cranial neuropathy, multiple

craniopharyngioma

cycad seed flour

cyst, epidermoid of CNS

DATATOP study

deep gray nuclei

degenerative diseases of CNS

dementia

deprenyl

depression

developmental retardation

dopa responsive dystonia

dopamine agonist

dopaminergic dysfunction

dopaminergic neurons

drug abuse

drug induced neurologic disorders

dyskinesia

dystonia

dystonia musculorum deformens

dystonia, classification

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

DYT1 mutation

embolism

encephalitis

encephalitis lethargica

encephalitis, Powassan

encephalitis, viral

encephalomyelitis, parainfectious

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, progressive

endocarditis

endocarditis, neurologic manifestations with

endocarditis, subacute bacterial

endocarditis, treatment of

ependymoma

epidemiology of neurology

epidermoid

excitotoxin

eye movement, disorders of

facial nerve palsy, bilateral

fibrinolytic agents, complications

fine motor function, impaired

fourth ventricle, compression

genetic neurologic disorders

glioblastoma multiforme(astrocytoma Gr.III)

hematuria, microscopic

hemianopia, homonymous

hepatolenticular degeneration(Wilson's disease)

herbicide

herniation syndromes, intracranial

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

insect sting

insecticides

intellectual deficit

internuclear ophthalmoplegia, unilateral

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, incidence of

intracerebral hemorrhage, recurrent

intracerebral hemorrhage, treatment of

intracerebral hemorrhage, young adult

intrathecal chemotherapy

Korsakoff's psychosis

L-dopa

L-dopa, drug interactions with and side effects of

leg spasms

leg spasms, painful

lenticular nucleus, lesion of, bilateral

leukemia, neurologic findings assoc.with

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

locus ceruleus, lesion of

lymphoma, primary of CNS

marche a petits pas

masked facies

medulloblastoma

meningeal enhancement

meningitis, carcinomatous

meningoencephalitis

meningoencephalopathy

mental status, abnormal

methotrexate

methylhydrazine derivatives

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, hyperkinetic

movement disorder, treatment of

MRI, contrast enhanced

MRI, diffusion weighted

neoplasm, intracranial

neoplasm, intracranial-incidence and epidemiology of

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-hemorrhage into

neoplasm, metastatic to CNS-treatment of

neoplasm, primary intracerebral

neoplasm, primary intracerebral, reoperation

neoplasm, primary intracranial-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-familial occurrence

neoplasm, primary of CNS-hemorrhage in

neoplasm, primary of CNS-incidence of

neoplasm, primary of CNS-treatment of

neuroleptic, atypical

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nigrostriatal pathway

nitrogen mustard

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

occupational neurologic disorders

oculogyric crisis

old age, neurology of

orthostatic hypotension

Osler's nodes

owl's eye sign of spinal cord

oxidative phosphorylation

oxidative phosphorylation defect

Parkinson disease, classification

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, dystonia with

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, late onset

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, racial prevalence

Parkinson disease, subtypes

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

pathology

patient information and support

pleocytosis of cerebrospinal fluid

poison, organophosphate

posterior fossa, lesion of

posterior fossa, mass of

postural abnormality

precipitating factors

prevention of neurologic disorders

PRKN gene

procarbazine

prognosis

progressive neurologic disorder

psychiatric disorder

psychiatric problems in neurologic disorders

psychosis

ptosis

ptosis, bilateral

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

raphe nuclei

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

recurrent

reversible neurologic disorder

sensorineural hearing loss

sensory tricks

serologic testing

sinemet

single photon emission computed tomography

spinal cord, lesion of

stem cell transplantation

stereotaxic surgery

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

thalamus, lesion of-bilateral

tick bite

tick-borne encephalitis

tinnitus

tonsillar herniation of cerebellum

torticollis

toxic encephalopathy

toxins, nervous system

transient ischemic attack

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

vincristine neurotoxicity

walking, difficulty with

Showing articles 0 to 50 of 3697 Next >>

Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024

MR Imaging Patterns and Prognosis in Powassan Virus Encephalitis
Neurologist doi.10.1097/NRI.0000000000000533, Finelli,P.F., 2023

The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022

Clinicopathologic Conference, Powassan Virus Encephalitis
NEJM 380:380-387, Case 3-2019, 2019

Viral Hepatitis and Parkinson Disease
Neurol 88:1630-1633, Pakpoor, J.,et al, 2017

Parkinson Disease Subtypes
JAMA 71:499-504, Thenganatt, M. & Jankovic, J., 2014

Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Encephalitis Lethargica (non Economo Disease, sleeping sickness)
Adams & Victors Principles of Neurology, Chp 33, pg 768, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Clinicopathologic Conference, West Nile Virus Infection, Case 15-2013
NEJM 368:1919-1927, Vyas, J.,et al, 2013

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Parkinson Disease, 10 Years After Its Genetic Revolution: Multiple Clues to a Complex Disorder
Neurol 69:2093-2104, Klein,C. &Schlossmacher,M.G., 2007

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

Pesticide Exposure and Risk for Parkinsons Disease
Ann Neurol 60:197-203, Ascherio,A.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005

Pathogenetic Mechanisms of Parkin in Parkinson's Disease
Lancet 364:722-724, Hattori,N. &Mizuno,Y., 2004

Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002

The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996

Diet and Parkinson's Diseae I:A Possible Role for the Past Intake of Specific Foods and Food Groups
Neurol 47:636-643, Hellenbrand,W.,et al, 1996

Generalized Mitochondrial Dysfunction in Parkinson's Disease Detected by Magnetic Resonance Spectroscopy of Muscle
Neurol 45:2097-2099, Penn,A.M.W.,et al, 1995

Kindreds of Dominantly Inherited Parkinson's Disease:Keys to the Riddle
Ann Neurol 38:355-356, Duvoisin,R.C.&Golbe,L.I., 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Cigarette Smoking and Protection from Parkinson's Disease:False Association or Etiologic Clue?
Neurol 45:1041-1051, Morens,D.M.,et al, 1995

Increased Risk of Parkinson's Disease in Parents and Siblings of Patients
Ann Neurol 36:659-661, Payami,H.,et al, 1994

Oxidative Damage in Neurodegenerative Disease
Lancet 344:796-798, Jenner,P., 1994

Mitochondrial Involvement in Parkinson's Disease:The Controversy Continues
Neurol 43:2170-2172, DiMauro,S., 1993

Identical Twins with Similar Onset of Parkinson's Disease:A Case Report
Neurol 43:1159-1161, Pahwa,R.,et al, 1993

Parkinson's Disease:A Test of the Multifactorial Etiologic Hypothesis
Neurol 43:1173-1180, Semchuk,K.M.,et al, 1993

Environmental Causation of Parkinson's Disease
Arch Neurol 50:651-652, Rajput,A.H., 1993

The Nonenvironmental Basis for Rising Mortality from Parkinson's Disease
Arch Neurol 50:653-656, Riggs,J.E., 1993

Risk Factors for Parkinson's Disease
Neurol 43:1693-1697, 16411993., Hubble,J.P.,et al, 1993

Environmental Antecedents of Young-Onset Parkinson's Disease
Neurol 43:1150-1158, Butterfield,P.G.,et al, 1993

The Free Radical Hypothesis in Idiopathic Parkinsonism:Evidence Against It
Ann Neurol 32:799-803, Calne,D.B., 1992

The Oxident Stress Hypothesis in parkinson's Disease:Evidence Supporting it
Ann Neurol 32:804-812, Fahn,S.&Cohen,G., 1992

Parkinson's Disease and Exposure to Agricultural Work and Pesticide Chemicals
Neurol 42:1328-1335, Semchuk,K.M.,et al, 1992

Stroke and Parkinson's Disease
Stroke 23:839-842, Levine,R.L.,et al, 1992

Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991

Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991

The Epidemiology of Parkinson's Disease, A Case-Control Study of Young-Onset and Old-Onset Patients
Arch Neurol 48:903-907, Stern,M.,et al, 1991

Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991

Mitochondrial Oxidative Phosphorylation Defects in Parkinson's Disease
Ann Neurol 30:332-339, 3301991., Shoffner,J.M.,et al, 1991

Environmental Risk Factors in Parkinson's Disease
Neurol 40:1218-1221, Koller,W.,et al, 1990

2-Amino-3- (methylamino) -Propanoic Acid (BMAA) in Cycad Flour:An Unlikely Cause of ALS & Parkinsonism-Dementia of Guam
Neurol 40:767-772, Duncan,M.W.,et al, 1990

Showing articles 0 to 50 of 3697 Next >>